Cost-effectiveness of red blood cell transfusion vs. non-intervention in women with acute anaemia after postpartum haemorrhage

Vox Sanguinis

Volumn 107, Issue 4, 2014, Pages 381-388

  Prick, B W ^a,b   Duvekot, J J ^a   van der Moer, P E ^b   van Gemund, N ^c   van der Salm, P C M ^d   Jansen, A J G ^a,e   van Rhenen, D J ^e   Mol, B W ^f   Uyl de Groot, C A ^g  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Maasstad Hospital Rotterdam   (Netherlands)

^c SINT FRANCISCUS GASTHUIS   (Netherlands)

^d MEANDER MEDICAL CENTER   (Netherlands)

^e CENTRAL LABORATORY   (Netherlands)

^f UNIVERSITY OF ADELAIDE   (Australia)

^g ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Anaemia; Cost effectiveness; Obstetric complication; Postpartum haemorrhage; Transfusion

Indexed keywords

FOLIC ACID; IRON;

ADULT; ANEMIA; ARTICLE; COMPARATIVE EFFECTIVENESS; CONSULTATION; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; ECONOMIC EVALUATION; ERYTHROCYTE TRANSFUSION; FATIGUE; FEMALE; HEALTH CARE COST; HEALTH CARE QUALITY; HEMOGLOBIN BLOOD LEVEL; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; POSTPARTUM HEMORRHAGE; TELECONSULTATION; VITAMIN SUPPLEMENTATION; CONTROLLED STUDY; COST BENEFIT ANALYSIS; ECONOMICS; HOSPITAL; PREGNANCY; PUERPERIUM; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SEVERITY OF ILLNESS INDEX;

ADULT; ANEMIA; COST-BENEFIT ANALYSIS; ERYTHROCYTE TRANSFUSION; FATIGUE; FEMALE; HOSPITALS; HUMANS; POSTPARTUM HEMORRHAGE; POSTPARTUM PERIOD; PREGNANCY; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX;

EID: 84912018042     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/vox.12181     Document Type: Article

References (19)

1. Emmanuel JC: The Clinical Use of Blood. Geneva, Switzerland, World Health Organization Blood Safety Unit, 2001
2. World Health Organisation: WHO Guidelines for the Management of Postpartum Haemorrhage and Retained Placenta. Geneva, Switzerland, World Health Organisation, 2009
3. Carroli G, Cuesta C, Abalos E, et al.: Epidemiology of postpartum haemorrhage: a systematic review. Best Pract Res Clin Obstet Gynaecol 2008; 22:999-1012
4. Jansen AJ, van Rhenen DJ, Steegers EA, et al.: Postpartum hemorrhage and transfusion of blood and blood components. Obstet Gynecol Surv 2005; 60:663-671
5. Prick BW, Jansen AJG, Steegers EAP, et al.: Transfusion policy after severe postpartum haemorrhage: a randomised non-inferiority trial. BJOG 2014; 121:1005-1014
6. Prick BW, Steegers EA, Jansen AJ, et al.: Well being of obstetric patients on minimal blood transfusions (WOMB trial). BMC Pregnancy Childbirth 2010; 10:83
7. Jansen AJ, Duvekot JJ, Hop WC, et al.: New insights into fatigue and health-related quality of life after delivery. Acta Obstet Gynecol Scand 2007; 86:579-584
8. Hakkaart-van Roijen L, Tan SS, Cam B: Handleiding voor kostenonderzoek, methoden en standaard kostprijzen voor economische evaluaties in de gezondheidszorg. Diemen, the Netherlands, College voor zorgverzekeringen, 2010
9. Nederlandse Zorgautoriteit: Available at: http://www.nza.nl/ [Last accessed 2 February 2014]
10. Zorgverzekeringen. Cv: Medicijnkosten.nl. Available at: http://www.medicijnkosten.nl/ [Last accessed 2 February 2014]
11. Zorginstituut Nederland: Pharmacotherapeutic Compass. Available at:http://www.farmacotherapeutischkompas.nl/ [Last accessed 2 February 2014]
12. Carson JL, Terrin ML, Noveck H, et al.: Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med 2011; 365:2453-2462
13. Hebert PC, Wells G, Blajchman MA, et al.: A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999; 340:409-417
14. Rohde JM, Dimcheff DE, Blumberg N, et al.: Health care-associated infection after red blood cell transfusion: a systematic review and meta-analysis. JAMA 2014; 311:1317-1326
15. Purcell A, Fleming J, Bennett S, et al.: Determining the minimal clinically important difference criteria for the Multidimensional Fatigue Inventory in a radiotherapy population. Support Care Cancer 2010; 18:307-315
16. Walters SJ, Brazier JE: Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual Life Res 2005; 14:1523-1532
17. Beliaev AM, Marshall RJ, Gordon M, et al.: Clinical benefits and cost-effectiveness of allogeneic red-blood-cell transfusion in severe symptomatic anaemia. Vox Sang 2012; 103:18-24
18. Carson JL, Grossman BJ, Kleinman S, et al.: Red blood cell transfusion: a clinical practice guideline from the AABB. Ann Intern Med 2012; 157:49-58
19. Carson JL, Hill S, Carless P, et al.: Transfusion triggers: a systematic review of the literature. Transfus Med Rev 2002; 16:187-199